Biocon gains on launching Tacrolimus capsules in US

29 Dec 2020 Evaluate

Biocon is currently trading at Rs. 466.70, up by 0.90 points or 0.19% from its previous closing of Rs. 465.80 on the BSE.

The scrip opened at Rs. 475.00 and has touched a high and low of Rs. 475.75 and Rs. 466.25 respectively. So far 133823 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 487.70 on 23-Dec-2020 and a 52 week low of Rs. 235.80 on 19-Mar-2020.

Last one week high and low of the scrip stood at Rs. 487.70 and Rs. 459.35 respectively. The current market cap of the company is Rs. 56196.00 crore.

The promoters holding in the company stood at 60.67%, while Institutions and Non-Institutions held 22.98% and 16.35% respectively.

Biocon has launched Tacrolimus capsules in the US. Tacrolimus, a calcineurin inhibitor, is an immunosuppressant used in the treatment of organ transplant patients, which reduces the body’s ability to reject a transplanted organ. It has been particularly effective in treating patients of renal transplant for more than two decades.

The launch of Tacrolimus capsules, following an approval from the United States Food and Drug Administration (USFDA) in November 2020, underscores Biocon’s relentless pursuit of its mission to make affordable healthcare accessible. The launch of Tacrolimus capsules in the US is another milestone for Biocon that reflects commitment to continually evaluate and expand portfolio of complex products to serve patients.

Biocon is India’s largest and Asia’s leading Biotechnology Company with a strategic focus on biopharmaceuticals and research services. It is a fully integrated, innovation driven biopharma enterprise offering affordable solutions for chronic diseases to patient's worldwide.

Biocon Share Price

306.00 -1.00 (-0.33%)
29-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1521.95
Dr. Reddys Lab 6279.95
Cipla 1407.55
Zydus Lifesciences 963.50
Lupin 1640.30
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.